Investors relieved at $572 million verdict in opioid trial; appeal planned

The Associated Press - August 27, 2019 2:29 pm

By The Associated Press

Johnson & Johnson investors exhaled in relief Tuesday, pushing up shares about 3 percent after an Oklahoma judge imposed a $572 million verdict late Monday for its role in the nation’s opioid crisis.

Investors had been holding their breath during a trial in which the state of Oklahoma, calling J&J a “kingpin” in the epidemic, sought up to $17 billion. The much-smaller verdict, and J&J’s immediate response that the verdict was “flawed” and it will appeal, reassured investors, for now.

“The risk of a loss was already baked into the stock price,” and this verdict doesn’t set a precedent for other cases, noted Erik Gordon, an analyst and professor at University of Michigan’s Ross School of Business.

 

Latest Stories

No. 9 OU women remain unbeaten with 88-58 victory over UNLV

LAS VEGAS (AP) — Senior Skylar Vann scored 15 points and her sister, freshman Zya Vann,...

Bryce Thompson scores 17 points and OSU beats Miami 80-74 in the Charleston Classic

CHARLESTON, S.C. (AP) — Bryce Thompson scored 17 points, Marchelus Avery had 15 points and eight...

Freshman Jeremiah Fears, Duke Miles propel OU to 84-56 victory over East Texas A&M

NORMAN, Okla. (AP) — Freshman Jeremiah Fears finished with 20 points, Duke Miles scored 19, and...